Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat

Kidney International

Volumn 65, Issue 1, 2004, Pages 209-218

  Griffin, Karen A ^a   Picken, Maria M ^a   Bidani, Anil K ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autoregulation; Hypertension; Radiotelemetry; Remnant kidney

Indexed keywords

AMLODIPINE; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY MASS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; TELEMETRY; UNINEPHRECTOMY;

EID: 0347362478     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00356.x     Document Type: Article

References (50)

1. PURKERSON ML, HOFFSTEN PE, KLAHR S: Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9:407-417, 1976
2. HOSTETTER TH, OLSON JL, RENNKE HG, et al: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85-F93, 1981
3. BRENNER BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324-F337, 1985
4. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
5. OLSON JL, HEPTINSTALL RH: Non-immunologic mechanisms of glomerular injury. Lab Invest 59:564-578, 1988
6. NEURINGER JR, BRENNER BM: Hemodynamic theory of progressive renal disease: A 10-year update in brief review. Am J Kidney Dis 22:98-104, 1993
7. ANDERSON S, MEYER TW, RENNKE HG, BRENNER BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76:612-619, 1985
8. BIDANI AK, MITCHELL KD, SCHWARTZ MM, et al: Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model. Kidney Int 38:28-38, 1990
9. BIDANI AK, GRIFFIN KA, PICKEN M, LANSKY DM: Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am J Physiol 265:F391-F398, 1993
10. GRIFFIN KA, PICKEN M, BIDANI A: Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model. Kidney Int 46:1010-1018, 1994
11. KLAHR S, LEVEY AS, BECK GJ, et al: The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877-884, 1994
12. JOINT NATIONAL COMMITTEE ON PREVENTION, DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD PRESSURE: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 157:2413-2446, 1997
13. BAKRIS GL, WILLIAMS M, DWORKIN L, et al: Preserving renal function in adults with hypertension and diabetes: A consensus approach. Am J Kidney Dis 36:646-661, 2000
14. BIDANI AK, GRIFFIN KA: Long-term renal consequences of hypertension for normal and diseased kidneys. Curr Opin Nephrol Hypertens 11:73-80, 2002
15. GRIFFIN KA, PICKEN M, BIDANI AK: Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. J Am Soc Nephrol 4:4023-2031, 1994
16. AMAN K, KOCH A, HOFSTETTER J, et al: Glomerulosclerosis and progression: Effect of subantihypertensive doses of α and β blockers. Kidney Int 60:1309-1323, 2001
17. GRETZ N, WALDHERR R, STRAUCH M: The remnant kidney model, in Experimental and Genetic Rat Models of Chronic Renal Failure, edited by Gretz N, Strasuch M, Basel, Karger, 1993, pp 1-28
18. YOSHIDA Y, FOGO A, ICHIKAWA I: Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis. Kidney Int 35:654-660, 1989
19. FOGO A, ICHIKAWA I: Evidence of central role of glomerular growth promoters in the development of sclerosis. Semin Nephrol 9:329-342, 1990
20. KETTELER M, NOBLE NA, BORDER WA: Transforming growth factor-β and angiotensin. II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 57:279-295, 1995
21. STRIKER GE, HE C: Biology of disease. Pathogenesis of non-immune glomerulosclerosis: Studies in animals and potential applications to humans. Lab Invest 73:596-605, 1995
22. FOGO AB: Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases. Kidney Int 57(Suppl 75):S15-S21, 2000
23. BIDANI AK, PICKEN MM, BAKRIS G, GRIFFIN KA: Lack of evidence of BP independent protection by renin-angiotensin system blockade after renal ablation. Kidney Int 57:1651-1661, 2000
24. TANAKA M, SCHIDLIN O, OLSON JL, et al: Chloride-sensitive renal microangiopathy in the stroke-prone spontaneously hypertensive rat. Kidney int 59:1066-1076, 2001
25. GRIFFIN KA, ABU-AMARAH I, PICKEN M, BIDANI AK: Renoprotection by ACE inhibition or aldosterone blockade is blood pressure dependent. Hypertension 41:201-206, 2003
26. KURTZ TW: Editorial commentary. False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system? Hypertension 41:193-196, 2003
27. GRIFFIN KA, BIDANI AK, OUYANG J, et al: Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction. Am J Physiol 264:R1254-R1259, 1993
28. FRY JC: Biological data analysis: A practical approach, in The Practical Series, edited by Rickwood D, Hames BD, New York, Oxford, OIRL Press at Oxford Univ Press, Inc., 1993
29. BIDANI AK, SCHWARTZ MM, LEWIS EJ: Renal autoregulation and vulnerability to hypertensive injury in remnant kidney. Am J Physiol 252:1003-1010, 1987
30. PELAYO JC, WESTCOTT JY: Impaired autoregulation of glomerular capillary hydrostatic pressure in the rat remnant nephrons. J Clin Invest 88:101-105, 1991
31. ARENDSHORST WJ, BEIERWALTES WH: Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol 263:F246-F251, 1979
32. NAVAR LG, INSCHO EW, MAJID DSA, et al: Paracrine regulation of the renal microcirculation. Physiol Rev 76:425-536, 1996
33. PALMER BF: Renal dysfunction complicating the treatment of hypertension. N Engl J Med 347:1256-1261, 2002
34. BIDANI AK, HACIOGLU R, ABU-AMARAH I, et al: 'Step' vs 'Dynamic' autoregulation: Implications for susceptibility to hypertensive injury. Am J Physiol 285:F113-F120, 2003
35. GRIFFIN KA, PICKEN MM, CHURCHILL M, et al: Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat. J Am Soc Nephrol 11:497-506, 2000
36. HOLSTEIN-RATHLOU NH, HE J, WAGNER AJ, MARSH DJ: Patterns of blood pressure variability in normotensive and hypertensive rats. Am J Physiol 269:R1230-R1239, 1995
37. HOLSTEIN-RATHLOU NH, MARSH DJ: Renal blood flow regulation and arterial pressure fluctuations: A case study in nonlinear dynamics. Physiol Rev 74:637-681, 1994
38. PERSSON PB: Modulation of cardiovascular control mechanisms and their interaction. Physiol Rev 76:193-244, 1996
39. LOUTZENHISER R, BIDANI A, CHILTON L: Renal myogenic response: Kinetic attributes and physiological role. Circ Res 90:1316-1324, 2002
40. UK PROSPECTIVE DIABETES STUDY GROUP: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. Br Med J 317:703-713, 1998
41. LEVY D: The role of systolic blood pressure in determining risk for cardiovascular disease. J Hypertens 17:S15-S18, 1999
42. STRAESSEN JA, GASOWSKI J, WANG JG, et al: Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 355:865-872, 2000
43. YOSHIDA Y, FOGO A, ICHIKAWA I: Effects of antihypertensive drugs on glomerular morphology. A close linkage between their anti-hypertrophic and anti-sclerotic action on remnant glomeruli. Kidney Int 36:626-635, 1989
44. GRIFFIN KA, PICKEN MM, BIDANI AK: Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys. J Clin Invest 96:793-800, 1995
45. GRIFFIN KA, PICKEN MM, BAKRIS GL, BIDANI AK: Comparative effects of T-and L-type calcium channel blockade in the remnant kidney model. Hypertension 37:268-1272, 2001
46. GRIFFIN KA, PICKEN M, GIOBBIE-HURDER A, BIDANI AK: Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory vs hypertrophic mechanisms. Kidney Int 63:607-616. 2003
47. LAFFERTY HM, BRENNER BM: Are glomerular hypertension and "hypertrophy" independent risk factors for progression of renal disease? Semin Nephrol 10:294-304, 1990
48. LAX DS, BENSTEIN JA, TOLBERT E, DWORKIN LD: Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys. Kidney Int 41:1527-1534, 1992
49. MILLER PL, RENNKE HG, MEYER TW: Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 261:F459-F465, 1991
50. NOVICK AC, GEPHARDT G, GUZ B, et al: Long-term follow-up after partial removal of solitary kidney. N Engl J Med 325:1058-1062, 1991